- CMV is the most common and serious viral infection in transplant patients - The cobas® CMV test provides reliable, reproducible, high-quality results for clinical decision-making - CMV viral load ...
MINNEAPOLIS/ST. PAUL (09/24/2025) — New research from the University of Minnesota Medical School confirms that testing for congenital cytomegalovirus (cCMV) at birth using the routinely collected ...
Assay will help monitor the effects of antiviral therapy in organ transplant patients. Roche’s Cobas® AmpliPrep/Cobas TaqMan® CMV test for evaluating cytomegalovirus (CMV) load received FDA premarket ...
Universal screening for congenital cytomegalovirus (CMV) in newborns, using dried blood spot analysis during the first week of life, created opportunities to intervene for improved outcomes, a ...
The state of New York plans to add testing for Cytomegalovirus, known as CMV, to its Newborn Screening Program beginning this fall. WSHU’s Madi Steddick spoke with Dr. Sharon Nachman, the division ...
Connecticut passes cytomegalovirus testing law Congenital cytomegalovirus is the leading cause of mental retardation and disability in children. Newborn infants who fail an initial hearing screen will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results